TickerFacts.

Company research / NATR

Nature's Sunshine Products Inc (NATR)

Build a valuation ↗↓ Download CSV

SEC name NATURES SUNSHINE PRODUCTS INC · CIK 0000275053 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated UT
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Nature's Sunshine Products Inc reported revenue of $480.14M. Revenue grew 5.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $492.02M.

Key ratios (year ended 2025-12-31)

72.4%
Gross margin
5.2%
Operating margin
4.3%
Net margin
12.7%
Return on year-end equity
5.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-15

Headquarters locality: Lehi · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$492.02M$480.14M$454.36M$445.32M$421.91M$444.08M$385.20M$362.21M$364.81M$342.03M$341.16M
Cost of Revenue$132.04M$132.42M$129.68M$124.19M$122.15M$115.47M$101.28M$93.94M$95.69M$91.04M$90.94M
Gross Profit$359.98M$347.72M$324.69M$321.13M$299.76M$328.62M$283.93M$268.27M$269.12M$250.99M$250.22M
R&D Expensen/a$1.90M$1.70M$1.60M$1.50M$1.40M$1.50M$2.10M$2.80M$3.40M$3.20M
Operating Income$29.32M$24.74M$20.09M$18.75M$16.26M$34.67M$21.48M$16.12M$5.35M$1.39M$10.04M
Depreciation & Amortization$13.37M$13.84M$14.22M$11.82M$11.03M$11.16M$10.74M$10.60M$9.81M$8.63M$4.81M
EBITDA$42.69M$38.59M$34.31M$30.57M$27.28M$45.83M$32.23M$26.72M$15.16M$10.02M$14.85M
Net Income$18.70M$20.45M$7.89M$16.42M$550.0K$30.21M$22.96M$6.93M-$1.20M-$13.82M$675.0K
EPS (Diluted)n/a$1.06$0.40$0.77-$0.02$1.42$1.07$0.34-$0.04-$0.69$0.11
Total Assets$259.82M$261.15M$240.85M$249.77M$229.78M$258.87M$249.50M$213.07M$193.02M$195.19M$205.57M
Total Liabilities$90.51M$99.59M$79.86M$90.23M$82.73M$97.47M$92.26M$83.63M$72.45M$75.46M$73.17M
Long-Term Debtn/an/an/an/a$1.17M$2.42M$3.72Mn/an/an/an/a
Shareholders' Equity$169.32M$161.55M$160.99M$159.54M$147.05M$161.40M$157.23M$129.44M$120.57M$119.73M$132.40M
Cash & Equivalents$82.50M$93.89M$84.70M$82.37M$60.03M$86.18M$92.07M$53.63M$50.64M$42.91M$32.28M
Operating Cash Flow$27.36M$35.32M$25.30M$41.23M$710.0K$34.61M$37.66M$8.54M$21.83M$10.52M$3.42M
Capital Expenditures$9.28M$6.48M$10.97M$10.48M$7.63M$6.67M$4.91M$5.10M$4.83M$5.50M$11.03M
Free Cash Flow$18.09M$28.84M$14.33M$30.75M-$6.92M$27.94M$32.75M$3.44M$17.00M$5.02M-$7.61M
Share Repurchases$6.52M$16.31M$8.86M$6.40M$13.57M$7.42M$0n/an/a$0$0
Dividends Paidn/an/an/an/a$0$19.86M$0n/a$0$1.85M$7.51M
Shares Outstanding17.61M17.51M18.48M18.88M19.09M19.72M19.70M19.41M19.20M18.92M18.76M
Dividends Per Sharen/an/an/an/a$0.00$1.00$0.00$0.00$0.00$0.10$0.40
Weighted Average Diluted Sharesn/a18.47M19.09M19.47M19.33M20.33M19.97M19.66M19.12M18.88M19.06M
EPS (Basic)n/a$1.08$0.41$0.79-$0.02$1.45$1.09$0.35-$0.04-$0.69$0.11

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView